A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study). (Q40299075)
Jump to navigation
Jump to search
scientific article published on 14 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study). |
scientific article published on 14 January 2012 |
Statements
1 reference
A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study). (English)
1 reference
C Sebban
1 reference
A Lefranc
1 reference
L Perrier
1 reference
P Moreau
1 reference
D Espinouse
1 reference
A Schmidt
1 reference
L Kammoun
1 reference
H Ghesquieres
1 reference
C Ferlay
1 reference
J O Bay
1 reference
S Lissandre
1 reference
D Pérol
1 reference
M Michallet
1 reference
P Quittet
1 reference
14 January 2012
1 reference
1 reference
48
1 reference
5
1 reference
713-720
1 reference
Identifiers
1 reference
1 reference